{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:48:31Z","timestamp":1771652911098,"version":"3.50.1"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":942,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>\n                                 <jats:bold>The development of potentially severe non-graft-versus-host disease (GVHD) hepatitis resembling autoimmune hepatitis (AIH) has been reported after bone marrow transplantation (BMT). The aim of this study was to better characterize this form of hepatitis, particularly through the identification of autoantigens recognized by patient sera. Five patients who received an allogeneic BMT for the treatment of hematological diseases developed liver dysfunction with histological features suggestive of AIH. Before and during the onset of hepatic dysfunction, sera were tested on immunoblottings performed with cytosolic, microsomal, mitochondrial, and nuclear proteins from rat liver homogenate and resolved by two-dimensional electrophoresis. Antigenic targets were identified by mass spectrometry. During the year that followed BMT, all patients presented with GVHD. Acute hepatitis then occurred after the withdrawal, or during the tapering, of immunosuppressive therapy. At that time, no patients had a history of liver toxic drug absorption, patent viral infection, or any histopathological findings consistent with GVHD. Immunoreactive spots stained by sera collected at the time of hepatic dysfunction were more numerous and more intensely expressed than those stained by sera collected before. Considerable patient-dependent pattern heterogeneity was observed. Among the 259 spots stained exclusively by sera collected at the time of hepatitis, a total of 240 spots were identified, corresponding to 103 different proteins. Twelve of them were recognized by sera from 3 patients.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>\n                                 <jats:bold>This is the first immunological description of potentially severe non-GVHD hepatitis occurring after BMT, determined using a proteomic approach and enabling a discussion of the mechanisms that transform an alloimmune reaction into an autoimmune response. Any decision to withdraw immunosuppression after allogeneic BMT should be made with caution.<\/jats:bold>\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/hep.26024","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T08:27:46Z","timestamp":1345624066000},"page":"689-699","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Immunoproteomic Analysis of Potentially Severe Non-Graft-Versus-Host Disease Hepatitis After Allogenic Bone Marrow Transplantation"],"prefix":"10.1097","volume":"57","author":[{"given":"Elvire","family":"Beleoken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolphe","family":"Sobesky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Le Caer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Le Naour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myl\u00e8ne","family":"Sebagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Moniaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Roche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Zahid","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Guettier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Johanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Henri","family":"Bouhris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Duclos-Vallee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Ballot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20241201","doi-asserted-by":"crossref","first-page":"S324S335","DOI":"10.1016\/j.jaci.2009.11.014","article-title":"Transplantation immunology: solid organ and bone marrow.","volume":"125","author":"Chinen","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl 2","key":"R2-28-20241201","first-page":"S58S64","article-title":"Acute GvHD: pathogenesis and classification.","volume":"41","author":"Ball","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R3-28-20241201","doi-asserted-by":"crossref","first-page":"215229","DOI":"10.1089\/152581602753658420","article-title":"A systematic approach to hepatic complications in hematopoietic stem cell transplantation.","volume":"11","author":"Arai","year":"2002","journal-title":"J Hematother Stem Cell Res"},{"key":"RU4-28-20241201","doi-asserted-by":"crossref","first-page":"441452","DOI":"10.1111\/j.1365-2036.2006.03001.x","article-title":"Review article: management of hepatic disease following haematopoietic cell transplant.","volume":"24","author":"McDonald","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-28-20241201","doi-asserted-by":"crossref","first-page":"573575","DOI":"10.1038\/sj.bmt.1705646","article-title":"Alloimmune hepatitis following peripheral stem cell transplantation.","volume":"39","author":"Habib","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"R6-28-20241201","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1111\/j.1432-2277.2009.01028.x","article-title":"Successful living donor liver transplantation for severe hepatic GVHD histologically resembling autoimmune hepatitis after bone marrow transplantation from the same sibling donor.","volume":"23","author":"Mori","year":"2010","journal-title":"Transpl Int"},{"key":"R7-28-20241201","doi-asserted-by":"crossref","first-page":"829832","DOI":"10.1038\/sj.bmt.1703923","article-title":"Autoimmune hepatitis following allogeneic PBSCT from an HLAmatched sibling.","volume":"31","author":"Ogose","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R8-28-20241201","doi-asserted-by":"crossref","first-page":"13131314","DOI":"10.1111\/j.1572-0241.2007.01782_7.x","article-title":"LKM1positive type 2 autoimmune hepatitis following allogenic hematopoietic stemcell transplantation.","volume":"103","author":"Granito","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R9-28-20241201","doi-asserted-by":"crossref","first-page":"703705","DOI":"10.1038\/sj.bmt.1705510","article-title":"Cytochrome P450 1A2 is a target antigen in hepatitic graftversushost disease.","volume":"38","author":"Mullighan","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R10-28-20241201","doi-asserted-by":"crossref","first-page":"600602","DOI":"10.1038\/bmt.2011.124","article-title":"Autoimmunelike hepatitis following unrelated BMT successfully treated with rituximab.","volume":"47","author":"Narita","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"R11-28-20241201","doi-asserted-by":"crossref","first-page":"634643","DOI":"10.1373\/49.4.634","article-title":"Identification of rat targets of antisoluble liver antigen autoantibodies by serologic proteome analysis.","volume":"49","author":"Ballot","year":"2003","journal-title":"Clin Chem"},{"key":"R12-28-20241201","doi-asserted-by":"crossref","first-page":"284290","DOI":"10.1016\/j.bbrc.2007.12.075","article-title":"Serum proteomicbased analysis for the identification of a potential serological marker for AIH.","volume":"367","author":"Lu","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"R13-28-20241201","doi-asserted-by":"crossref","first-page":"937948","DOI":"10.1002\/hep.22149","article-title":"Identification of plasma membrane autoantigens in AIH type 1 using a proteomics tool.","volume":"47","author":"Tahiri","year":"2008","journal-title":"HEPATOLOGY"},{"key":"R14-28-20241201","doi-asserted-by":"crossref","first-page":"604617","DOI":"10.1042\/bj0600604","article-title":"Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in ratliver tissue.","volume":"60","author":"De Duve","year":"1955","journal-title":"Biochem J"},{"key":"R15-28-20241201","doi-asserted-by":"crossref","first-page":"16621665","DOI":"10.1126\/science.154.3757.1662","article-title":"Nuclei from rat liver: isolation method that combines purity with high yield.","volume":"154","author":"Blobel","year":"1966","journal-title":"Science"},{"key":"R16-28-20241201","doi-asserted-by":"crossref","first-page":"36653685","DOI":"10.1002\/pmic.200401031","article-title":"Current twodimensional electrophoresis technology for proteomics.","volume":"4","author":"Gorg","year":"2004","journal-title":"Proteomics"},{"key":"R17-28-20241201","doi-asserted-by":"crossref","first-page":"43504354","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.","volume":"76","author":"Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"RU18-28-20241201","doi-asserted-by":"crossref","first-page":"850858","DOI":"10.1021\/ac950914h","article-title":"Mass spectrometric sequencing of proteins silverstained polyacrylamide gels.","volume":"68","author":"Shevchenko","year":"1996","journal-title":"Anal Chem"},{"key":"R19-28-20241201","doi-asserted-by":"crossref","first-page":"14721480","DOI":"10.1053\/j.gastro.2011.02.010","article-title":"Comparability of probable and definite AIH by international diagnostic scoring criteria.","volume":"140","author":"Czaja","year":"2011","journal-title":"Gastroenterology"},{"key":"R20-28-20241201","doi-asserted-by":"crossref","first-page":"48192","DOI":"10.1136\/jcp.2008.058248","article-title":"Histological patterns in druginduced liver diseases.","volume":"62","author":"Ramachandran","year":"2009","journal-title":"J Clin Pathol"},{"key":"R21-28-20241201","doi-asserted-by":"crossref","first-page":"167175","DOI":"10.1016\/j.bbmt.2010.07.017","article-title":"Diagnosis and staging of chronic graftversushost disease in the clinical practice.","volume":"17","author":"Greinix","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"RU22-28-20241201","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.blre.2005.01.007","article-title":"Chronic graftversushost disease.","volume":"20","author":"Horwitz","year":"2006","journal-title":"Blood Rev"},{"key":"R23-28-20241201","doi-asserted-by":"crossref","first-page":"24562463","DOI":"10.1172\/JCI28349","article-title":"Immunoprivileged status of the liver is controlled by Tolllike receptor 3 signaling.","volume":"116","author":"Lang","year":"2006","journal-title":"J Clin Invest"},{"key":"R24-28-20241201","doi-asserted-by":"crossref","first-page":"142150","DOI":"10.1016\/j.bbmt.2007.10.023","article-title":"Chronic graftversushost disease: how can we release Prometheus?","volume":"14","author":"Teshima","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"R25-28-20241201","doi-asserted-by":"crossref","first-page":"119128","DOI":"10.1016\/j.beha.2008.02.001","article-title":"The thymus in GVHD pathophysiology.","volume":"21","author":"Krenger","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"RU26-28-20241201","doi-asserted-by":"crossref","first-page":"63016305","DOI":"10.1073\/pnas.87.16.6301","article-title":"Thymus: a direct target tissue in graftversushost reaction after allogeneic bone marrow transplantation that results in abrogation of induction of selftolerance.","volume":"87","author":"Fukushi","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-28-20241201","doi-asserted-by":"crossref","first-page":"196370","DOI":"10.1021\/pr700861s","article-title":"Autoantibody profiling of Chinese patients with autoimmune hepatitis using immunoproteomic analysis.","volume":"7","author":"Xia","year":"2008","journal-title":"J Proteome Res"},{"key":"R28-28-20241201","doi-asserted-by":"crossref","first-page":"119125","DOI":"10.1016\/j.autrev.2006.07.004","article-title":"Clinical and biological aspects of antiPribosomal protein autoantibodies.","volume":"6","author":"Toubi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"R29-28-20241201","doi-asserted-by":"crossref","first-page":"376382","DOI":"10.1111\/j.1365-3083.2006.01747.x","article-title":"Antip97VCP antibodies: an autoantibody marker for a subset of primary biliary cirrhosis patients with milder disease?","volume":"63","author":"Miyachi","year":"2006","journal-title":"Scand J Immunol"},{"key":"R30-28-20241201","doi-asserted-by":"crossref","first-page":"568573","DOI":"10.1111\/j.1365-2249.2004.02456.x","article-title":"Autoantibodies from primary biliary cirrhosis patients with antip95c antibodies bind to recombinant p97VCP and inhibit in vitro nuclear envelope assembly.","volume":"136","author":"Miyachi","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"R31-28-20241201","doi-asserted-by":"crossref","first-page":"734741","DOI":"10.1016\/S0168-8278(00)80241-X","article-title":"Clinical significance of antineutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.","volume":"32","author":"Roozendaal","year":"2000","journal-title":"J Hepatol"},{"key":"R32-28-20241201","doi-asserted-by":"crossref","first-page":"745753","DOI":"10.1016\/j.molimm.2005.03.011","article-title":"Amino acids critical for binding of autoantibody to an immunodominant conformational epitope of the pyruvate dehydrogenase complex subunit E2: identification by phage display and sitedirected mutagenesis.","volume":"43","author":"Scealy","year":"2006","journal-title":"Mol Immunol"},{"key":"R33-28-20241201","first-page":"3241","article-title":"Evaluation of two cell surface modification methods for proteomic analysis of plasma membrane from isolated mouse hepatocytes.","volume":"1794","author":"Li","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"RU34-28-20241201","doi-asserted-by":"crossref","first-page":"30293037","DOI":"10.1021\/pr060366w","article-title":"Global profiling of surface plasma membrane proteome of oviductal epithelial cells.","volume":"5","author":"Sostaric","year":"2006","journal-title":"J Proteome Res"},{"key":"R35-28-20241201","first-page":"123131","article-title":"Occurrence of cytotoxic autoantibody in rabbits by immunization with heterologous liver arginase: a possible implication in the mechanism of the autoimmune liver diseases.","volume":"59","author":"Mafune","year":"1985","journal-title":"Clin Exp Immunol"},{"key":"R36-28-20241201","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1055\/s-0031-1272834","article-title":"De novo AIH after liver transplantation.","volume":"31","author":"Guido","year":"2011","journal-title":"Semin Liver Dis"},{"key":"RU37-28-20241201","doi-asserted-by":"crossref","first-page":"345357","DOI":"10.1196\/annals.1398.041","article-title":"Identification by proteomic tool of atypical antiliverkidney microsome autoantibodies targets in de novo AIH after liver transplantation.","volume":"1109","author":"Huguet","year":"2007","journal-title":"Ann N Y Acad Sci"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhep.26024","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T14:06:55Z","timestamp":1733062015000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01515467-201302000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1002\/hep.26024","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}